What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Immune system
Mark Boguniewicz spends much of his time researching Atopic dermatitis, Immunology, Allergy, Atopy and Psoriasis.
His Atopic dermatitis research is classified as research in Dermatology.
His Dermatology research is multidisciplinary, incorporating elements of Susceptibility gene, Adverse effect and 2,4-Dinitrochlorobenzene.
His Immunology study often links to related topics such as Skin infection.
His Allergy study frequently links to related topics such as Asthma.
His biological study spans a wide range of topics, including Guideline, Clinical immunology and Eczema Area and Severity Index.
His most cited work include:
- Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis (1536 citations)
- New insights into atopic dermatitis (1142 citations)
- Cytokine modulation of atopic dermatitis filaggrin skin expression (730 citations)
What are the main themes of his work throughout his whole career to date?
Mark Boguniewicz mostly deals with Atopic dermatitis, Dermatology, Immunology, Allergy and Atopy.
His research on Atopic dermatitis focuses in particular on Eczema Area and Severity Index.
As a part of the same scientific study, Mark Boguniewicz usually deals with the Dermatology, concentrating on Quality of life and frequently concerns with Cross-sectional study.
His study in Immunology concentrates on Immunopathology, Immune system, Psoriasis, Immunoglobulin E and Innate immune system.
His Allergy research is multidisciplinary, incorporating perspectives in Incidence and Cytokine.
The study incorporates disciplines such as Skin biopsy and Pathogenesis in addition to Cytokine.
He most often published in these fields:
- Atopic dermatitis (83.33%)
- Dermatology (40.99%)
- Immunology (40.09%)
What were the highlights of his more recent work (between 2017-2021)?
- Atopic dermatitis (83.33%)
- Dermatology (40.99%)
- Dupilumab (8.11%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Atopic dermatitis, Dermatology, Dupilumab, Dermatology Life Quality Index and Severity of illness.
Atopic dermatitis and In patient are two areas of study in which Mark Boguniewicz engages in interdisciplinary research.
The Dermatology study combines topics in areas such as Moderate to severe, Exacerbation, Phosphodiesterase 4 Inhibitor and Adult patients.
His Dupilumab research is multidisciplinary, relying on both Lebrikizumab, Eczema Area and Severity Index, Immune dysregulation, Tralokinumab and Post-hoc analysis.
His research in Severity of illness intersects with topics in Disease and Comorbidity.
His work deals with themes such as Crisaborole and Immunology, which intersect with Boxed warning.
Between 2017 and 2021, his most popular works were:
- Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study (108 citations)
- Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial. (72 citations)
- Atopic dermatitis yardstick: Practical recommendations for an evolving therapeutic landscape (72 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Immune system
His primary areas of investigation include Atopic dermatitis, Quality of life, Severity of illness, Dermatology Life Quality Index and Internal medicine.
To a larger extent, Mark Boguniewicz studies Dermatology with the aim of understanding Atopic dermatitis.
His study looks at the relationship between Severity of illness and topics such as Comorbidity, which overlap with Hay fever, Disease, Pharmacotherapy and Alopecia areata.
The various areas that he examines in his Dupilumab study include Clinical trial, Regimen, Randomized controlled trial, Adverse effect and Concomitant.
His work carried out in the field of Asthma brings together such families of science as Psychological intervention, Family medicine, Allergy, Public health and Transplantation.
His Eczema Area and Severity Index study is concerned with Immunology in general.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
